tetano
Editor, Senior Moderator
Dtsch Med Wochenschr. 2011 Nov;136(45):2315-8. Epub 2011 Nov 2.
[Comparison of seasonal influenza vaccines: composition and properties].
[Article in German]
Allwinn R, Doerr HW.
Source
Institut f?r Med. Virologie und Impfambulanz, Frankfurt/Main.
Abstract
The influenza virus isolation in embryonated chicken eggs was possible early in 1930er years and allowed the influenza vaccine production. Most influenza vaccines were derived from this, but actually new virus cell culture methods are established. For better tolerability, influenza vaccines include only antigen proportions (split- and subunit vaccines) but with the disadvantage of minor vaccine efficacy. This was compared with the addition of adjuvants. Aluminium salts are used for many decades and still in use to enhance the effect of vaccines. New formulations are MF59, AS03, AS04 or toll- like receptor-agonists. Also virosomal formulations and "ISCOMs"(Immune Stimulating Complexes) are newly designed and compromises enhanced immune reactions. Actually a broad range of various influenza vaccines exist and are available for a very different group of patients (which depends on physical conditions, age, immune status or allergies).
? Georg Thieme Verlag KG Stuttgart ? New York.
PMID:
22048938
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/22048938
[Comparison of seasonal influenza vaccines: composition and properties].
[Article in German]
Allwinn R, Doerr HW.
Source
Institut f?r Med. Virologie und Impfambulanz, Frankfurt/Main.
Abstract
The influenza virus isolation in embryonated chicken eggs was possible early in 1930er years and allowed the influenza vaccine production. Most influenza vaccines were derived from this, but actually new virus cell culture methods are established. For better tolerability, influenza vaccines include only antigen proportions (split- and subunit vaccines) but with the disadvantage of minor vaccine efficacy. This was compared with the addition of adjuvants. Aluminium salts are used for many decades and still in use to enhance the effect of vaccines. New formulations are MF59, AS03, AS04 or toll- like receptor-agonists. Also virosomal formulations and "ISCOMs"(Immune Stimulating Complexes) are newly designed and compromises enhanced immune reactions. Actually a broad range of various influenza vaccines exist and are available for a very different group of patients (which depends on physical conditions, age, immune status or allergies).
? Georg Thieme Verlag KG Stuttgart ? New York.
PMID:
22048938
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/22048938